Full-Time

CQV Engineer

Posted on 10/31/2025

Automated Systems of Tacoma

Automated Systems of Tacoma

51-200 employees

Aseptic fill-finish equipment for sterile injectables

Compensation Overview

$90k - $140k/yr

+ Bonus

Tacoma, WA, USA

In Person

Category
Biology & Biotech (2)
,
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • B.S. or M.S. in Engineering (Industrial, Mechanical, Process, or Chemical) or a related technical discipline.
  • 5–8 years as a Validation Engineer in the pharmaceutical or medical device industry.
  • At least 4 years of hands-on experience commissioning, qualifying, and validating filling and isolator systems in biotech/pharma manufacturing environments.
  • Proficient in validation lifecycle documentation: URS, FRS, DS, IQ, OQ, PQ, PV, CSV, MVP, and more.
  • Solid understanding of cGxP principles, ISO 13485, ISO 14971, 21 CFR Part 820, and EU Annex 1.
  • Working knowledge of Computer Systems Validation (CSV) and quality systems such as Change Control, Non-Conformances, and Requalification.
  • Strong technical writing, presentation, and documentation skills.
  • Excellent analytical, problem-solving, time management, and decision-making capabilities.
  • Demonstrated ability to manage multiple projects, work independently, and support cross-functional teams.
  • Highly proficient in Microsoft Office tools (Word, Excel, PowerPoint).
  • Effective communication, leadership, and interpersonal skills with a focus on customer service and results.
  • Must be legally authorized to work in the United States without restriction.
  • Must be willing to take and successfully pass a drug test.
Responsibilities
  • Lead qualification and validation activities (IQ, OQ, PQ) for filling line isolators in compliance with regulatory standards and company procedures.
  • Develop, execute, and approve validation protocols, test scripts, and reports for equipment commissioning and performance verification.
  • Provide quality oversight and technical support during validation efforts, including reviewing and approving documentation such as URSs, P&IDs, specifications, and SOPs.
  • Collaborate with cross-functional teams (engineering, manufacturing, QA, regulatory) to ensure project alignment and compliance.
  • Perform risk assessments and troubleshooting issues during validation to minimize project delays.
  • Maintain accurate and detailed documentation within the electronic document management system for audit readiness.
  • Support the development of Validation Master Plans, Equipment Validation Reports, and Summary Reports.
  • Assist with resolution of deviations, change controls, and validation-related issues during equipment builds and installations.
  • Attend project meetings, contribute to SOP development, and perform additional duties as needed to support validation objectives.
  • >50% travel required.
Automated Systems of Tacoma

Automated Systems of Tacoma

View

Automated Systems of Tacoma (AST) designs, builds, and services aseptic fill-finish machines for sterile injectable products and life sciences. Its equipment automates the process of filling and packaging ready-to-use nested vials, cartridges, and syringes under aseptic conditions, enabling reliable manufacturing of sterile products in pharmaceutical and biotechnology settings. The machines are designed to be flexible to accommodate different formats and regulatory requirements, and AST also offers ongoing service and support based on its five decades of experience in the field. Compared with competitors, AST emphasizes a long track record, close customer relationships, and a focus on tailoring high-automation equipment to meet stringent product and regulatory needs. The company’s goal is to provide dependable, adaptable aseptic processing solutions that help customers manufacture sterile products efficiently and in compliance with regulations.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Tacoma, Washington

Founded

1965

Simplify Jobs

Simplify's Take

What believers are saying

  • Marchesini acquires 44.39% stake, expanding AST's global reach.
  • Jacob Stephen joins as COO on August 7, 2025.
  • Charisse Curtis appointed CCO to boost business development.

What critics are saying

  • Marchesini dilutes AST control, prioritizing packaging over isolators.
  • AST Environmental newsletters cause ongoing brand confusion.
  • Competitors erode GENiSYS edge with faster robotics at INTERPHEX 2025.

What makes Automated Systems of Tacoma unique

  • AST partners with Marchesini Group for sterile fill-finish expertise.
  • AST launches Shield glove tester and digital twin tool in 2025.
  • AST showcases GENiSYS C ATMP line at INTERPHEX 2025.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

Stock Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Relocation Assistance

Employee Referral Bonus

Student Loan Assistance

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Childcare Support

Elder Care Support

Pet Insurance

Bereavement Leave

Professional Development Budget

Conference Attendance Budget

Training Programs

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Wellness Program

Mental Health Support

Gym Membership

Commuter Benefits

Meal Benefits

Phone/Internet Stipend

Home Office Stipend

Legal Services

Employee Discounts

Company Social Events

Company News

PharmaSource
Dec 10th, 2025
AST Announces Strategic Partnership with Marchesini Group to Strengthen Sterile Fill-Finish Capabilities - PharmaSource

AST has entered a strategic partnership with the Marchesini Group to enhance global capabilities in sterile fill-finish and drug product manufacturing. The companies said the…

PR Newswire
Aug 8th, 2025
AST Names Industry Veteran Jacob Stephen as Chief Operating Officer

TACOMA, Wash., Aug. 7, 2025 /PRNewswire/ - AST is pleased to announce that Jacob Stephen will be joining the AST Team as Chief Operations Officer at the Tacoma-headquartered drug product equipment manufacturing company.

PR Newswire
Apr 30th, 2025
Ast Celebrates 60 Years Of Excellence In Innovation And Looks To The Future Of Drug Product Manufacturing

This milestone celebration sets the stage for AST's next phase of strategic growth, anchored by its revitalized Mission, Vision, and Purpose statementsTACOMA, Wash., April 30, 2025 /PRNewswire/ -- AST marked the launch of its 60th anniversary year at INTERPHEX 2025, using the prestigious industry event as a springboard to highlight six decades of innovation. Building on the momentum of being named "Best in Show" at INTERPHEX 2024, AST entered its 60th anniversary receiving another reputable honor: the INTERPHEX Efficiency Champion award. This back-to-back recognition highlights not only AST's legacy of innovation but also its forward-looking approach to advancing excellence across the industry.AST was founded in Tacoma, Washington, in 1965. From the beginning, the company pursued a clear vision: provide advanced automated manufacturing solutions driven by a commitment to quality engineering, American ingenuity, and a customer-first approach. Now, for six decades, AST has been a leader in the advanced manufacturing space, and in 2004, the company leveraged its combined expertise and experience to begin providing flexible automation for life science applications.AST's initial success was found in innovative manufacturing solutions designed and built by a small team of engineers, including prototypes and first-of-its-kind technologies that would set new standards in what was possible with automation. These early solutions would serve as the foundation for the later technologies that AST would become recognized for

The Prescott Times
Apr 30th, 2025
AST Celebrates 60 Years of Excellence in Innovation and Looks to the Future of Drug Product Manufacturing

Now in 2025, AST is marking the next chapter in its mission to support the future of pharmaceutical manufacturing by expanding its portfolio with the introduction of the Shield(TM) glove integrity testing system and its digital suite of products and services with the launch of its digital twin tool - a preview of AST's' advanced solutions dedicated to digital and data integration.

AST, Inc.
Mar 17th, 2025
AST Announces New Chief Commercial Officer, Charisse Curtis

Charisse Curtis has joined AST as Chief Commercial Officer, leading the Business Development, Marketing, and Communications teams.

INACTIVE